Skip to main content

Table 1 Logrank testing for GP88 score cut-off establishment in the training trial

From: Progranulin (GP88) tumor tissue expression is associated with increased risk of recurrence in breast cancer patients diagnosed with estrogen receptor positive invasive ductal carcinoma

GP88 scores

DFS

OS

Between

Chi-squared

P

Chi-squared

P

1 and 0

1.35

0.2459

2.06

0.1512

2 and 0, 1

0.21

0.6430

0.01

0.9159

3 and 0, 1, 2

17.07

0.00004

8.46

0.0036